Dx Focus: BD Max StaphSR Assay; Roche Cobas CT/NG v2.0 Test | GenomeWeb

Becton Dickinson said this week that it has received US Food and Drug Administration clearance to market BD Max StaphSR Assay for use on the BD Max automated molecular testing system.

The new assay is designed to detect Staphylococcus aureus and methicillin-resistant S. aureus DNA directly from nasal swabs in approximately two hours. It can detect mecA dropout mutants and other new strains of MRSA that may not be detected by other assays, BD said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.